| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.29 | 0.05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |